Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SMB Technology is a Belgian pharmaceutical company specializing in the development and manufacturing of innovative oral dosage forms and respiratory products. The company focuses on advanced drug delivery systems, including sustained-release and controlled-release technologies like Lidose and G-Spheres, to improve the efficacy and safety of existing active ingredients. SMB operates as a fully integrated pharmaceutical group, providing services ranging from galenic research and development to large-scale GMP manufacturing. Their product portfolio primarily covers therapeutic areas such as cardiovascular health, respiratory medicine, and pain management. They are particularly recognized for their expertise in pelletization and dry powder inhaler (DPI) technologies, serving both as a product developer and a contract development and manufacturing organization (CDMO).
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on S.M.B. Technology.